David Roth - Net Worth and Insider Trading
David Roth Net Worth
The estimated net worth of David Roth is at least $0 dollars as of 2025-04-02. David Roth is the Chief Medical Officer of Syros Pharmaceuticals Inc and owns about 0 shares of Syros Pharmaceuticals Inc (SYRS) stock worth over $0. Details can be seen in David Roth's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Roth has not made any transactions after 2024-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Roth
David Roth Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Roth owns 3 companies in total, including Syros Pharmaceuticals Inc (SYRS) , Infinity Pharmaceuticals Inc (INFIQ) , and Allarity Therapeutics Inc (ALLR) .
Click here to see the complete history of David Roth’s form 4 insider trades.
Insider Ownership Summary of David Roth
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2024-11-18 | Chief Medical Officer |
| INFIQ | Infinity Pharmaceuticals Inc | 2014-01-31 | Chief Medical Officer |
| ALLR | Allarity Therapeutics Inc | 2022-07-07 | director |
David Roth Latest Holdings Summary
David Roth currently owns a total of 1 stock. David Roth owns 0 shares of Syros Pharmaceuticals Inc (SYRS) as of November 18, 2024, with a value of $0.
Latest Holdings of David Roth
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2024-11-18 | 0 | 0.02 | 0 |
Holding Weightings of David Roth
David Roth Form 4 Trading Tracker
According to the SEC Form 4 filings, David Roth has made a total of 6 transactions in Syros Pharmaceuticals Inc (SYRS) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Syros Pharmaceuticals Inc is the sale of 12,099 shares on November 18, 2024, which brought David Roth around $2,420.
Insider Trading History of David Roth
- 1
David Roth Trading Performance
David Roth Ownership Network
Ownership Network List of David Roth
Ownership Network Relation of David Roth
David Roth Owned Company Details
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
David Roth is the Chief Medical Officer of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include director & 10 percent owner & President & CEO Nancy A Simonian , Chief Legal Officer Gerald E Quirk , and Chief Development Officer Kristin Stephens .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
Over the past 18 months, David Roth made 5 insider transaction in Syros Pharmaceuticals Inc (SYRS) with a net sale of 35,274. Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 171,783 shares made by Nancy A Simonian , a net sale of 37,803 shares made by Jason Haas , and a net sale of 34,797 shares made by Chee Conley .
In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 562,447 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 542,530 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
David Roth Mailing Address
Above is the net worth, insider trading, and ownership report for David Roth. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David Roth's mailing address is: Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
